Carolina Liquid Chemistries Offers Microalbumin Reagent for Clinical Chemistry Analyzer
The K-ASSAY Microalbumin reagent is intended for the quantitative determination of human albumin in urine by immunoturbidimetric assay.
The K-ASSAY Microalbumin reagent is intended for the quantitative determination of human albumin in urine by immunoturbidimetric assay.
BioSPME (Bioanalytical Solid Phase MicroExtraction), has been developed to provide a high throughput automatable cleaner sample
The Native Antigen Company announced the launch of its latest SARS-CoV-2 antigens for the newly designated omicron BA.5 variant.
The NAB-Sure SARS-CoV-2 Neutralizing Antibody Test Kit helps researchers better understand COVID immune response and validate vaccines.
Read MoreGenScript USA, a subsidiary of GenScript Biotech Corp., announced the immediate availability of a monkeypox virus PCR test kit.
Read MoreThe U.S. Food and Drug Administration (FDA) has approved a label expansion for Roche’s VENTANA MMR RxDx Panel.
Read MoreMeridian Bioscience received re-authorization from the FDA of its Emergency Use Authorization (EUA) for a SARS-COV-2 molecular assay.
Read MoreBD and CerTest Biotec announced their newly developed molecular PCR test for the monkeypox virus is commercially available outside the U.S.
Read MoreARUP Laboratories has begun in-house testing for the monkeypox virus with its Orthopoxvirus by RT-PCR test.
Read MoreThe BD MAX Respiratory Viral Panel is a diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV).
Read MoreSeegene, a molecular diagnostics (MDx) company, has developed a PCR test designed to detect the monkeypox virus.
Read MoreCo-Diagnostics completed the principal design work of a PCR test for the monkeypox virus, which is exhibiting a multi-country outbreak.
Read MoreSeegene unveiled a global initiative for preemptive and routine PCR COVID-19 testing to help individuals stay healthy during the pandemic.
Read MoreLumiraDx’s rapid COVID-19 antigen assay, LumiraDx SARS-CoV-2 Ag Test received the Emergency Use Listing by the World Health Organization.
Read MoreNext-generation point-of-care diagnostics company LumiraDx announced that its quick SARS-CoV-2 Ag Ultra Test achieved CE Marking.
Read MoreAlamar and Mologic are collaborating to utilize Alamar’s novel antibodies against SARS-CoV-2 Nucleocapsid protein for future COVID tests.
Read MoreRevival Health was awarded as the exclusive distributor of Xiamen Boson Biotech’s Rapid SARS-CoV-2 Antigen Tests following a joint agreement.
Read MoreHORIBA Medical announces that its novel hemostatic D-dimer immunoassay, Yumizen G DDi 2, has been independently validated.
Read More